Article Impact Level: HIGH Data Quality: STRONG Summary of JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2026.4023 Dr. David J. Douin et al.
Points
- The multicenter SAVE-O2 AI trial enrolled 300 hospitalized adults across four U.S. medical centers to evaluate autonomous continuous oxygen titration.
- Automated oxygen delivery maintained target oxygen saturation 85% of the time compared with only 63% achieved through standard manual clinician titration.
- Real-time continuous monitoring via pulse oximetry significantly reduced patient exposure to dangerous periods of hypoxemia and hyperoxemia throughout treatment.
- Closed-loop oxygen management reduced the frequency of manual interventions, mitigating workload burdens for inpatient nurses and respiratory therapists.
- Preclinical and clinical evidence supports expanding autonomous oxygen delivery systems into prehospital transport and high-stress military combat casualty management.
Summary
This study evaluated the efficacy and safety of an autonomous oxygen titration system (O2matic PRO100) compared to standard clinician-managed care in maintaining target oxygen saturation (SpO2) ranges in hospitalized patients. Supplemental oxygen therapy is routinely administered to acutely ill medical, surgical, trauma, and burn patients to prevent tissue hypoxia. However, standard intermittent manual titration by clinical staff frequently allows peripheral oxygen levels to drift outside therapeutic parameters, exposing patients to periods of sub-therapeutic hypoxemia or tissue-damaging hyperoxemia.
The prospective multicenter randomized controlled SAVE-O2 AI trial enrolled 300 hospitalized adults across four U.S. medical centers, including UCHealth University of Colorado Hospital. Participants receiving new supplemental oxygen for acute respiratory illness, trauma, burns, or surgical recovery were randomly assigned to standard intermittent manual titration or real-time continuous titration using the autonomous pulse oximetry-guided system. The automated system continuously monitored SpO2 via digital pulse oximetry and dynamically adjusted oxygen flow rates without requiring manual clinician intervention.
Patients managed with autonomous oxygen titration spent 85% of their total treatment time within the designated target oxygen range, compared to 63% in the standard care cohort. Real-time autonomous regulation significantly reduced patient exposure to both hypoxemia and hyperoxemia while decreasing the frequency of required manual adjustments by nursing and respiratory therapy staff. No increase in serious adverse events was observed in the automated group, demonstrating that autonomous titration improves oxygen precision and offers clinical utility for civilian inpatient units and resource-constrained military combat environments.
Link to the article: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2852401
References
Douin, D. J., Rice, J. D., Xiao, M., Beaty, L. E., Guo, C. J., Withers, C., Sullivan, A., Anderson, E. L., Cheng, A. C., Banasiewicz, M. K., Semler, M. W., Lloyd, B. D., Maiga, A. W., Gibbs, K. W., Stettler, G. R., Khan, A., Sally, M. B., Wright, F. L., Wiktor, A. J., … Ward, D. (2026). Autonomous oxygen titration for maintaining normoxemia in acutely ill adults: The save-o2 ai randomized clinical trial. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2026.4023
